Bergman Alan B.

Bergman Alan B. is listed in public filings as officer: Chief Financial Officer. This Bergman Alan B. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include 20/20 Biolabs, Inc. Common Stock (AIDX). Investors use Bergman Alan B.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.